21
NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin Wolf*,** * University Hospital Zurich (USZ) ** University of Zurich (UZH) *** Swiss Federal Institute of Technology in Zurich (ETH) Switzerland

NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

Embed Size (px)

Citation preview

Page 1: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

NIROT for imaging of hypoxia in cancer tumors

(preclinical study)Alexander Kalyanov*,

Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin Wolf*,**

* University Hospital Zurich (USZ)** University of Zurich (UZH)

*** Swiss Federal Institute of Technology in Zurich (ETH)

Switzerland

Page 2: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

MotivationOxygenation of tumor tissue is one of the most important indicators of how aggressive the tumor is. As shown on the plots, tumor hypoxia presents a significant risk for patients and can decrease survival probability by factor of 2. Information about tumor oxygenation could help in prognosis and in choosing a treatment strategy.Despite the high importance of in vivo measurement of oxygenation in tumors, there is currently no technique available.

2

Radiation + Surgery

Survival probability comparison between hypoxic tumors (pO2<10mm/Hg) and normoxic ones (pO2≥10mm/Hg)

Page 3: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

The goal of this study is

To develop a continuous wave multispectral near-infrared optical tomography (mNIROT) technique for determining the oxygenation state of tissue in small animals. This would give information about the blood supply when studying the tumor microenvironment under hypoxic conditions. Such a setup for animals would be a step towards the development of NIROT for humans in the future.

3

Page 4: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

State of the art

Several different hypoxia imaging techniques are available at the moment for small animals, however they are either invasive and/or expensive. They measure different parameters that can be related to hypoxia, however they cannot provide a quantitative oxygenation value

• FMT: requires DNA modified cancer cells that produce fluorescence proteins in the presence of hypoxia inducible factors (HIF).

• Bioluminescence: require ODD-luciferase transgenic mice that spontaneously produce a protein consisting of HIF-1 α oxygen-dependent degradation domain (ODD) fused to luciferase.

• FMISO-PET: images pO2 in tissue, which can be correlated to StO2 with the oxygen dissociation curve (pH and temperature dependent)

4

Page 5: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

Why near-infrared optical tomography?

5

• Quantitative measurements of StO2 without contrast agents

due to the combination of the multispectral approach and the finite elements method (FEM) it becomes possible to reconstruct the concentration of absorbers, such as oxy- and deoxyhemoglobin, in a highly scattering medium with arbitrary shape

• Non-invasive radiationlight at 650-850 nm wavelengths range is used

• Scalable to humansbeing non-invasive and employing neither contrast agents nor DNA modification, the NIROT approach could be scaled to investigate tissue oxygenation in the human body in the future

Page 6: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

How does it work?

6

Multispectral NIROT is a combination of diffuse optical tomography (DOT) and near-infrared spectroscopy (NIRS) – the intensity of diffused light at different wavelengths is measured and used for further reconstruction of the absorbers’ concentrations

• The main absorbers in tissue are:

– oxyhemoglobin (O2Hb) and

– deoxyhemoglobin (HHb)• Hemoglobin is the main oxygen

transporter in tissue. Therefore, tissue oxygen saturation StO2 can be calculated by: StO2 = O2Hb / (O2Hb + HHb)

transparency window and typical wavelength range of NIRS

798 nm

Page 7: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

7

Reconstruction algorithm

Hypoxia

Image adapted from: Ntziachristos V., Fluorescence Molecular Tomography, Annu. Rev. Eng. 2006.8:1-33.

NIROT principle

An object is illuminated by light at several points called sources and diffused light is registered by detectors. We used a CCD camera for detection of light.

Each pixel of the camera is used as a separate detector for further reconstruction of the tissue’s optical properties.

Page 8: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

The multispectral approach in NIROT is possible due to the different absorption curves of oxy- and deoxyhemoglobin. Measurements at different wavelengths make it possible to quantify oxygenation of tissue in the volume under investigation.As shown on the plot, the oxyhemoglobin HbO2 absorbs less at wavelengths below 798nm while deoxyhemoglobin HHb absorbs less at wavelengths above 798nm.

Multispectral NIROT

8

Page 9: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

Self-calibrated mNIROT

9

680 nm / 760nm

830 nm / 760nm

830nm

760 nm

680 nm

Absorption [1/(mM*mm)]:HbO2=0.10, HHb=0.61

Absorption [1/(mM*mm)]:HbO2=0.15, HHb=0.38

Absorption [1/(mM*mm)]:HbO2=0.23, HHb=0.18

We implemented a wavelength normalisation approach to avoid calibration of the setup which is a typical diffuse optical tomography problem. To the best of our knowledge this is the first time this approach has been used for in vivo measurements. By using the ratio between measurements at two different wavelengths (instead of absolute values) we made the system self-calibrated so no measurements of homogeneous mediums are needed. The approach also removes the influence of background tissue.

Page 10: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

mNIROT system for animals

10

CCD

wavelength tunable laser

lens

galvo scanner

mirror 2 3D-scanning of surface

anesthesia

mirror 1 NIROT

transmissionmode

reflectionmode

An animal was placed on a stage with a transparent glass window and anesthetized. The stage was equipped with a heating system to warm up the animal during the experiment.

A laser beam scans the bottom surface through the glass window and diffused light is registered by CCD-camera. The CCD was focused on the animal’s surface by the lens.

Page 11: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

mNIROT system for animals

11

Technical details

camera

Andor DV434-BV

laser sourc

e

Fianium SC450 (8 W total output power) with AOTF NIR1 (650÷1100 nm, 2-5 nm bandwidth, ~20mW output)

Measurement details

3D scanning

NIROT

wavelength, nm

650 700, 735, 760, 798,

820

measurement time

10’ 20’

number of sources

700 24

typical exposure time,

sec

0.05 0.5-1.5

illumination mode

reflection transmission

Photo of the setup shielded from ambient light

The mNIROT is based on FMT setup provided by Prof. M.Rudin (Institute for Biomedical Engineering, ETH and UZH)

CCD

illuminationsystem

anaesthesia suppler

galvo scanner

reflection mode

mirror

object position

er

Page 12: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

3D-scanning of an object shape

12

Real animal

In order to improve the reconstruction quality we implemented 3D-scanning of the object surface and used information of its geometry to calculate the weight matrix by FEMMore than 700 laser spot positions were

used for the 3D-surface scanning, captured one after another. A shift of

each spot corresponds to surface altitude at this particular point

Page 13: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

RAW data for 798nm

13

Here is an example of RAW experimental data imposed on the volume of a mouse. 24 source positions on the bottom surface of the animal for each of the wavelengths* were used. Diffused light was captured by a CCD camera (256x256 detectors), the field of view (FOV) was about 74x74 mm.

white-light imageRAW data for 798 nm for all the sources

* a set of 700, 735, 760, 798 and 820 nm wavelengths

Page 14: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

Reconstruction

14

* NIRFAST is an open source software package for MATLAB® environment created by Dartmouth college

http://www.dartmouth.edu/~nir/nirfast/

• We used an extensively modified NIRFAST* package for reconstructions. The software was adapted for the wavelength normalisation approach.

• Homemade software is employed for pre-processing, filtering and validation of RAW data.

• Tetrahedron size of mesh was set to 1mm for the forward problem resulting in ~9000 nodes. The size was increased up to 2mm for bulk tissue and was kept 1mm for the tumor region in case of inverse problem to improve computation time. This leads to ~2000 nodes in the same volume.

• The computation time reached 7 minutes for the whole reconstruction process (desktop PC, i7-4770 CPU @ 3.40 GHz, 16 GB RAM).

Page 15: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

Reconstruction

15

hypoxic region in tumor

hypoxic regionin tumor

spleen

artefacts due to low resolution of mesh out of ROI (tumor)

YZ-plane

XZ-plane

XY-plane

3D view

StO2 distribution over the mouse body on the 32nd day after injection of tumor cells.

•reconstructed average StO2 in body is 52%;•average StO2 in the tumor is 41%;•minimum StO2 in the tumor is 8%.

spleen

liver

liver

spleen

Page 16: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

Validation of NIROT: histology of the tumor

16

The tumor tissue is stained to highlight hypoxic areas in red. These areas are characterized by extremely low partial oxygen pressure pO2<10 mmHg (which means that oxygen saturation is not higher than StO2<20%).

red – hypoxia (pimonidazole staining on the top figure and HIF staining on the bottom figure)green – GFP contained in the cellsblue – nuclei of the cells

The histological sample was taken on the 37th day after injection of tumor cells

The pimonidazole staining shows presence of highly hypoxic tissue (StO2<20%), which agrees well with the NIROT data

Page 17: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

Long-term study of tumors’ hypoxia

17

tumor cells:mice type:

tumor cells injection:

DLD-1 wt n°6 HRE-iRFPBALB/c nude, femaleright flank, subcutaneously

The study was carried out in mice. Tumor cells were injected subcutaneously to a batch of 4 mice. NIROT measurements were performed during the next 37 days starting with the 4th day. 9 datasets were obtained for each mouse except one which died on the 15th day of the experiment* (#274534).

4

days after injection:

7 10

15 18 23

29 32 37

* Nevertheless the data from the first 4 measurements of it was used in the following statistics

Page 18: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

Long-term study of tumors’ hypoxia

18

Oxygen saturation of tissue was reconstructed for each measurement. The average values of StO2 of all animals and its standard deviation (SD) are shown on the plot.

Please go to the next slide for more details.

Page 19: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

Long-term study of tumors’ hypoxia

19

Reconstructed StO2 values have a similar dynamic for all animals. Average tumor oxygenation appears to be lower than bulk tissue all the time except the first measurement (the 4th day after injection of tumor cells). At the first 15 days a decrement of StO2 was observed in all three monitored parameters: bulk tissue StO2

B, average tumor StO2AT and local

spatial minimum in tumor area StO2min. Although the minimum StO2

reached extremely low values of about 5%, which is 40% lower than the bulk tissue, the average StO2 in tumors did not drop down below 28% and stayed 10-15% lower than the background during first 29 days of experiment.

After the 15th day StO2 increased and almost reached initial values at day 29. The difference between StO2

B and StO2AT reduced to 7%. StO2

AT grew up to 44% and StO2

min up to 34%, both shown maximum values since the first week of tumor growth.The last 2 measurements were performed after necrotic processes started in the tumors. The reconstruction algorithm was not adapted to handle necrotic tissue. Therefore the data could be misinterpreted in this time interval.

Page 20: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

Conclusion

• The concept of multispectral NIROT with wavelength normalisation approach was proven for hypoxia imaging– geometry information was taken into account and NIRFAST software

was employed

– quantitative measurements of StO2 concentration of highly heterogeneous mouse tissue were performed with high spatial resolution

• Long-term study of the dynamics of tumor hypoxia on a mice model was performed– hypoxia dynamic was measured during 37 days in a batch of 4 mice,

the measured trends are in good correlation between animals– the data correlates with HIF-1α activity in hypoxic tumors [M.Rudin at

all, 2009]

20

Page 21: NIROT for imaging of hypoxia in cancer tumors (preclinical study) Alexander Kalyanov*, Juan Mata Pavia*, Catherine Germanier***, Markus Rudin***, Martin

Thank you for your attention!

21

The work was supported by: